Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Cinainu is effective and safe for treating children's alopecia areata.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

JAK inhibitors partially restore scalp bacteria balance in alopecia areata patients.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Gut bacteria differences may influence alopecia areata.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

4-aminopyridine speeds up and improves skin wound healing.

Alopecia areata in infants may be more common than previously thought.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

People with severe hair loss (Alopecia Areata) have different scalp bacteria than healthy people, which might help predict the condition's progress.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

The supplement aims to improve care for children with alopecia areata.

Sunscreen use is linked to frontal fibrosing alopecia, especially in males.

More lesions mean more severe alopecia areata.

Targeting the narrowest part of the anterior chamber angle may help prevent pupil block in glaucoma.

Alopecia areata often starts before age 20, is more common in women, and may have a genetic link with other autoimmune diseases.

Trichoscopy shows black dots, yellow dots, and empty follicles are common in Alopecia Areata, with broken and exclamation mark hair as typical patterns.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.